Osteoporosis Medicine By Dolphin Pharma
Dolphin Pharma offers a trusted range of Osteoporosis Medicine developed to support the management and treatment of bone loss. Our medicines are formulated with a strong focus on quality, safety, and treatment reliability. We aim to assist healthcare professionals in delivering effective bone care through consistent pharmaceutical solutions. Each product is manufactured following strict quality and regulatory standards
Bonimet (Ibandronic Acid) 6 mg / 6ml
Generic Name: Ibandronic Acid 6mg
Dolphin Pharmacutical offers an Osteoporosis medicines are used to prevent and treat osteoporosis, a condition that weakens bones and increases the risk of fractures. These medicines help maintain bone density, improve bone strength, and reduce the likelihood of fractures, particularly in older adults and individuals at increased risk. Various types of osteoporosis medicines are available, including bisphosphonates, denosumab, selective oestrogen receptor modulators, and anabolic agents. Each medication works differently to slow bone breakdown or stimulate new bone formation, depending on the patient's condition and treatment requirements. Bisphosphonates are commonly prescribed to reduce bone loss and lower the risk of fractures. Other treatments, such as denosumab, may help slow bone breakdown, while bone-forming medicines stimulate the development of new bone tissue in selected patients with severe osteoporosis or a high risk of fractures. Osteoporosis medicines are often recommended for postmenopausal women, older adults, and individuals with low bone density or a history of fragility fractures. The choice of treatment depends on factors such as age, fracture risk, medical history, kidney function, and response to previous therapies. In addition to medication, maintaining healthy bones requires adequate calcium and vitamin D intake, regular weight-bearing exercise, and appropriate lifestyle changes. Avoiding smoking, limiting alcohol consumption, and taking measures to prevent falls can also help support bone health and reduce fracture risk. Osteoporosis treatment should be planned and monitored by a qualified healthcare professional. Regular assessments may be recommended to evaluate bone density, treatment effectiveness, and potential side effects. Patients should follow the prescribed dosage and seek medical advice before starting, stopping, or changing any osteoporosis medication.